César Cuadra-SánchezAlexandra RiveroCarlos CabreraPedro FaneitePaulino Vigil‐De Gracia2026-03-222026-03-22202110.47307/gmc.2021.129.2.15https://doi.org/10.47307/gmc.2021.129.2.15https://andeanlibrary.org/handle/123456789/55909Citaciones: 2Pregnant women who have COVID-19 have an increased risk of hospitalization and death; however, there are many restrictions for the application of COVID-19 vaccines on pregnant patients, mainly because there is no confirmation of the safety of their use during pregnancy. None of the vaccines approved to date are based on live attenuated SARS-CoV-2, so the possibility of generating an infection in the fetus is nonexistent.enCoronavirus disease 2019 (COVID-19)MedicinePregnancySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakFetusObstetricsVirologyPrevention of COVID-19 in pregnant women, eventual use of new vaccinesarticle